The COBAS INTEGRA 400/400 plus system (software version 3.4) is a fully automated, computerized c...

FDA Device Recall #Z-0490-2013 — Class II — July 16, 2012

Recall Summary

Recall Number Z-0490-2013
Classification Class II — Moderate risk
Date Initiated July 16, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Molecular Systems, Inc.
Location Branchburg, NJ
Product Type Devices
Quantity 855 units.

Product Description

The COBAS INTEGRA 400/400 plus system (software version 3.4) is a fully automated, computerized chemistry analyzer. It is intended for in vitro quantitative or qualitative determination of a wide range of analytes in various body fluids.

Reason for Recall

Roche Molecular Systems, Inc. has become aware of a device-associated diagnostic software issue.

Distribution Pattern

Nationwide Distribution

Lot / Code Information

Device-associated diagnostic software

Other Recalls from Roche Molecular Systems, Inc.

Recall # Classification Product Date
Z-1104-2023 Class II cobas SARS-CoV-2 & Influenza A/B Qualitative as... Dec 21, 2022
Z-1106-2023 Class II cobas Influenza A/B & RSV UC (Utility Channel) ... Dec 21, 2022
Z-1105-2023 Class II cobas SARS-CoV-2 & Influenza A/B Qualitative nu... Dec 21, 2022
Z-0097-2023 Class II cobas 5800 instrument, Material No. 08707464001... Sep 8, 2022
Z-0828-2022 Class II cobas LiatSystem, respiratory virus panel nucle... Nov 16, 2021

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.